# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA645712 | F | Compound was evaluated for the inhibition of replication and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
2. | ALA645857 | F | Compound was evaluated for the inhibition of infectivity and cytopathic effect of HIV-1 in ATH8 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
3. | ALA646752 | B | Km by adenosine deaminase | 1 | single protein format | Scientific Literature | |||
4. | ALA644407 | B | Vmax by adenosine deaminase | 1 | single protein format | Scientific Literature | |||
5. | ALA659411 | F | Cytotoxic concentration required to inhibit the replication of HIV-1 in CEM-SS human T4 lymphoblastoid cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
6. | ALA653537 | F | Effective concentration required to inhibit the replication of HIV-1 in CEMSS human T4 lymphoblastoid cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
7. | ALA682810 | F | Concentration that reduces Friend murine leukemia virus titer by 50% | Mus musculus | 13 | organism-based format | Scientific Literature | ||
8. | ALA692262 | F | Compound was tested for inhibition of HIV-1 | Human immunodeficiency virus 1 | 1 | organism-based format | Scientific Literature | ||
9. | ALA689612 | F | Antiviral activity against HIV-1 was determined; No inhibition | Human immunodeficiency virus 1 | 15 | organism-based format | Scientific Literature | ||
10. | ALA694016 | F | Antiviral activity against HCMV was determined; No inhibition | Human betaherpesvirus 5 | 15 | organism-based format | Scientific Literature | ||
11. | ALA705839 | F | Compound was evaluated for the clonogenic assay with murine leukemia L1210 cells | Mus musculus | 1 | cell-based format | Scientific Literature | ||
12. | ALA708212 | F | Cytotoxicity was evaluated against L1210 leukemia cell line at 1000 ug/disk. | Mus musculus | 5 | cell-based format | Scientific Literature | ||
13. | ALA706592 | F | Inhibition of incorporation of labeled precursor into macromolecules of noninfected SC-1 cells with the compound at a concentration 100 uM determined against leucine. | 3 | cell-based format | Scientific Literature | |||
14. | ALA706593 | F | Inhibition of incorporation of labeled precursor into macromolecules of noninfected SC-1 cells with the compound at a concentration 300 uM determined against leucine. | 3 | cell-based format | Scientific Literature | |||
15. | ALA711275 | F | Cytotoxic concentration required to inhibit the replication of HIV-1 in MT-4 human T4 lymphoblastoid cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
16. | ALA712409 | F | Effective concentration required to inhibit the replication of HIV-1 in MT-4 human T4 lymphoblastoid cell lines | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
17. | ALA708373 | F | Cytotoxic concentration required to inhibit the replication of HIV-1 in MT-2 human T4 lymphoblastoid cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
18. | ALA706771 | F | Effective concentration required to inhibit the replication of HIV-1 in MT-2 human T4 lymphoblastoid cell lines | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
19. | ALA741866 | F | Inhibitory activity against murine leukemia L1210 cells | Mus musculus | 41 | cell-based format | Scientific Literature | ||
20. | ALA746239 | F | Cytotoxicity was evaluated | Mus musculus | 11 | organism-based format | Scientific Literature |